| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.22e-05 | 118 | 181 | 8 | GO:0003774 | |
| GeneOntologyCellularComponent | microtubule associated complex | 1.16e-05 | 161 | 181 | 9 | GO:0005875 | |
| GeneOntologyCellularComponent | presynaptic active zone | 3.22e-05 | 141 | 181 | 8 | GO:0048786 | |
| GeneOntologyCellularComponent | synaptic membrane | CACNA2D1 CACNA2D2 NTRK2 RIMS3 OPRL1 ARRB2 AP2B1 NAPB PTPRO KCNMA1 LRP1 ANP32E PRKCG LRRC7 CTNNA2 MUSK | 5.01e-05 | 583 | 181 | 16 | GO:0097060 |
| GeneOntologyCellularComponent | muscle myosin complex | 3.29e-04 | 16 | 181 | 3 | GO:0005859 | |
| Domain | - | APPBP2 CLTCL1 SGTA MAU2 UNC45A KLC4 TTC1 TRRAP TTC19 NAPB LONRF2 KDM6A CRTAP | 1.04e-07 | 207 | 179 | 13 | 1.25.40.10 |
| Domain | TPR-like_helical_dom | APPBP2 CLTCL1 SGTA MAU2 UNC45A KLC4 TTC1 TRRAP TTC19 NAPB LONRF2 KDM6A CRTAP | 4.06e-07 | 233 | 179 | 13 | IPR011990 |
| Domain | TPR | 4.26e-06 | 129 | 179 | 9 | SM00028 | |
| Domain | TPR_repeat | 5.48e-06 | 133 | 179 | 9 | IPR019734 | |
| Domain | Groucho_enhance | 8.54e-06 | 5 | 179 | 3 | IPR009146 | |
| Domain | TLE_N | 8.54e-06 | 5 | 179 | 3 | PF03920 | |
| Domain | Groucho/TLE_N | 8.54e-06 | 5 | 179 | 3 | IPR005617 | |
| Domain | TPR_10 | 1.70e-05 | 6 | 179 | 3 | PF13374 | |
| Domain | TPR_REGION | 3.10e-05 | 165 | 179 | 9 | PS50293 | |
| Domain | TPR | 3.10e-05 | 165 | 179 | 9 | PS50005 | |
| Domain | - | COP1 WDR27 BIRC6 DNAI1 TLE2 TLE3 TLE4 MIOS LRBA PLXNA1 PLXNA2 FBXW7 | 9.19e-05 | 333 | 179 | 12 | 2.130.10.10 |
| Domain | WD40/YVTN_repeat-like_dom | COP1 WDR27 BIRC6 DNAI1 TLE2 TLE3 TLE4 MIOS LRBA PLXNA1 PLXNA2 FBXW7 | 9.73e-05 | 335 | 179 | 12 | IPR015943 |
| Domain | TPR-contain_dom | 1.01e-04 | 150 | 179 | 8 | IPR013026 | |
| Domain | ARM-type_fold | CLTCL1 TNPO2 RANBP6 PPP6R1 UNC45A TRRAP HEATR6 AP2B1 EIF4G2 INTS4 ATM LRBA | 1.09e-04 | 339 | 179 | 12 | IPR016024 |
| Domain | TPR_1 | 2.28e-04 | 90 | 179 | 6 | IPR001440 | |
| Domain | TPR_1 | 2.28e-04 | 90 | 179 | 6 | PF00515 | |
| Domain | Myosin_N | 3.62e-04 | 15 | 179 | 3 | PF02736 | |
| Domain | Myosin_N | 3.62e-04 | 15 | 179 | 3 | IPR004009 | |
| Domain | Kinesin-like_KIF1-typ | 5.41e-04 | 4 | 179 | 2 | IPR022140 | |
| Domain | VDCC_a2/dsu | 5.41e-04 | 4 | 179 | 2 | IPR013680 | |
| Domain | KIF1B | 5.41e-04 | 4 | 179 | 2 | PF12423 | |
| Domain | VGCC_alpha2 | 5.41e-04 | 4 | 179 | 2 | PF08473 | |
| Domain | Myosin_tail_1 | 6.35e-04 | 18 | 179 | 3 | PF01576 | |
| Domain | Myosin_tail | 6.35e-04 | 18 | 179 | 3 | IPR002928 | |
| Domain | LRR | 7.28e-04 | 201 | 179 | 8 | PS51450 | |
| Domain | Myosin-like_IQ_dom | 7.49e-04 | 19 | 179 | 3 | IPR027401 | |
| Domain | - | 7.49e-04 | 19 | 179 | 3 | 4.10.270.10 | |
| Domain | VWA_N | 8.96e-04 | 5 | 179 | 2 | IPR013608 | |
| Domain | VWA_N | 8.96e-04 | 5 | 179 | 2 | PF08399 | |
| Domain | WD40 | 1.15e-03 | 268 | 179 | 9 | SM00320 | |
| Domain | Leu-rich_rpt | 1.24e-03 | 271 | 179 | 9 | IPR001611 | |
| Domain | WD40_repeat | 1.27e-03 | 272 | 179 | 9 | IPR001680 | |
| Domain | Kinesin_assoc | 1.34e-03 | 6 | 179 | 2 | PF16183 | |
| Domain | Kinesin-like | 1.34e-03 | 6 | 179 | 2 | IPR022164 | |
| Domain | FAT | 1.34e-03 | 6 | 179 | 2 | PS51189 | |
| Domain | FATC | 1.34e-03 | 6 | 179 | 2 | PS51190 | |
| Domain | Kinesin_assoc | 1.34e-03 | 6 | 179 | 2 | IPR032405 | |
| Domain | FAT | 1.34e-03 | 6 | 179 | 2 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 1.34e-03 | 6 | 179 | 2 | IPR003151 | |
| Domain | FATC_dom | 1.34e-03 | 6 | 179 | 2 | IPR003152 | |
| Domain | DUF3694 | 1.34e-03 | 6 | 179 | 2 | PF12473 | |
| Domain | PIK_FAT | 1.34e-03 | 6 | 179 | 2 | IPR014009 | |
| Domain | FATC | 1.34e-03 | 6 | 179 | 2 | SM01343 | |
| Domain | - | 1.38e-03 | 222 | 179 | 8 | 1.25.10.10 | |
| Domain | EGF_CA | 1.42e-03 | 86 | 179 | 5 | PF07645 | |
| Domain | WD_REPEATS_1 | 1.48e-03 | 278 | 179 | 9 | PS00678 | |
| Domain | WD_REPEATS_2 | 1.52e-03 | 279 | 179 | 9 | PS50082 | |
| Domain | WD_REPEATS_REGION | 1.52e-03 | 279 | 179 | 9 | PS50294 | |
| Domain | TPR_8 | 1.66e-03 | 53 | 179 | 4 | PF13181 | |
| Domain | WD40_repeat_dom | 2.32e-03 | 297 | 179 | 9 | IPR017986 | |
| Domain | BIR | 2.46e-03 | 8 | 179 | 2 | PF00653 | |
| Domain | BIR_REPEAT_2 | 2.46e-03 | 8 | 179 | 2 | PS50143 | |
| Domain | BIR | 2.46e-03 | 8 | 179 | 2 | SM00238 | |
| Domain | - | 2.46e-03 | 8 | 179 | 2 | 1.10.1170.10 | |
| Domain | BIR_rpt | 2.46e-03 | 8 | 179 | 2 | IPR001370 | |
| Domain | BIR_REPEAT_1 | 2.46e-03 | 8 | 179 | 2 | PS01282 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 7.32e-05 | 239 | 130 | 10 | MM14756 | |
| Pathway | REACTOME_REPRESSION_OF_WNT_TARGET_GENES | 8.77e-05 | 10 | 130 | 3 | MM15156 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 8.82e-05 | 26 | 130 | 4 | MM14793 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | USP53 FUT10 CACNA2D2 RTEL1 SGTA AFF3 SREBF2 SMURF1 WDR27 INTS3 TRRAP TTC19 OPRL1 CUL5 BMPR2 ARRB2 GALNT11 TLE3 EXOC6B KCNMA1 LRP1 ANKIB1 LRRC7 ASPSCR1 GNAS LRBA MCF2L KDM6A ZRANB1 CLBA1 INVS | 6.69e-11 | 1489 | 184 | 31 | 28611215 |
| Pubmed | PPP6R1 UNC45A BIRC6 ARRB2 KIF15 N4BP2 TLE3 TLE4 LRP1 ANKRD28 CRYBG3 LRBA L3MBTL3 NPAT | 5.85e-08 | 418 | 184 | 14 | 34709266 | |
| Pubmed | APPBP2 RIMS3 SMURF1 PPP6R1 TLE3 TLE4 MCM3AP ACIN1 LRRC7 MCF2L SIPA1L2 SLC9A6 PLXNA2 | 3.03e-07 | 407 | 184 | 13 | 12693553 | |
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 8948582 | ||
| Pubmed | 5.80e-07 | 4 | 184 | 3 | 20357587 | ||
| Pubmed | 5.80e-07 | 4 | 184 | 3 | 8645603 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | USP53 KIF13B GRK7 ARHGEF5 UNC45A KLC4 FSIP2 VPS13D BMPR2 MTUS1 N4BP2 PRKCG AKAP11 CRYBG3 GNAS SIPA1L2 KIF13A MUSK | 8.49e-07 | 861 | 184 | 18 | 36931259 |
| Pubmed | 1.45e-06 | 5 | 184 | 3 | 8365415 | ||
| Pubmed | Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development. | 1.45e-06 | 5 | 184 | 3 | 12919077 | |
| Pubmed | 1.45e-06 | 5 | 184 | 3 | 1303260 | ||
| Pubmed | Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro. | 1.45e-06 | 5 | 184 | 3 | 3829126 | |
| Pubmed | 1.45e-06 | 5 | 184 | 3 | 22288532 | ||
| Pubmed | 1.45e-06 | 5 | 184 | 3 | 6196357 | ||
| Pubmed | 2.88e-06 | 6 | 184 | 3 | 1728586 | ||
| Pubmed | 2.88e-06 | 6 | 184 | 3 | 8573724 | ||
| Pubmed | Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. | 2.88e-06 | 6 | 184 | 3 | 10077619 | |
| Pubmed | Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development. | 2.88e-06 | 6 | 184 | 3 | 10588881 | |
| Pubmed | A Gro/TLE-NuRD corepressor complex facilitates Tbx20-dependent transcriptional repression. | 5.02e-06 | 7 | 184 | 3 | 24024827 | |
| Pubmed | 5.02e-06 | 7 | 184 | 3 | 35210422 | ||
| Pubmed | 5.02e-06 | 7 | 184 | 3 | 16819597 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | USP53 KIF13B MYH2 SGTA PPP6R1 UNC45A TRRAP CUL5 AP2B1 ALDH16A1 EIF4G2 LRP1 MIOS ANKRD28 USP4 LONRF2 ZRANB1 CRTAP | 7.28e-06 | 1005 | 184 | 18 | 19615732 |
| Pubmed | Nolz1 promotes striatal neurogenesis through the regulation of retinoic acid signaling. | 8.00e-06 | 8 | 184 | 3 | 20735826 | |
| Pubmed | 8.00e-06 | 8 | 184 | 3 | 16002402 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | OLAH MYH1 APPBP2 TNPO2 ZBTB41 PPP6R1 BIRC6 AFAP1L2 GALNT11 ALDH16A1 MCM3AP ANP32E LRRC7 ATM LONRF2 | 9.77e-06 | 736 | 184 | 15 | 29676528 |
| Pubmed | Global genetic analysis in mice unveils central role for cilia in congenital heart disease. | 1.60e-05 | 100 | 184 | 6 | 25807483 | |
| Pubmed | 1.68e-05 | 209 | 184 | 8 | 36779422 | ||
| Pubmed | Acceleration of somitic myogenesis in embryos of myogenin promoter-MRF4 transgenic mice. | 1.70e-05 | 10 | 184 | 3 | 8950513 | |
| Pubmed | 1.70e-05 | 10 | 184 | 3 | 30571765 | ||
| Pubmed | SMURF1 RANBP6 UNC45A CUL5 ARRB2 MCM3AP EIF4G2 LRP1 PPP1R37 ANKRD28 KIF13A KDM6A INVS | 1.77e-05 | 591 | 184 | 13 | 15231748 | |
| Pubmed | 2.33e-05 | 11 | 184 | 3 | 8136524 | ||
| Pubmed | Coexpression of Cux-1 and Notch signaling pathway components during kidney development. | 2.33e-05 | 11 | 184 | 3 | 15499562 | |
| Pubmed | Myosin heavy chain-embryonic regulates skeletal muscle differentiation during mammalian development. | 2.75e-05 | 33 | 184 | 4 | 32094117 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 21730052 | ||
| Pubmed | Myosin heavy chains IIa and IId are functionally distinct in the mouse. | 2.78e-05 | 2 | 184 | 2 | 9585413 | |
| Pubmed | BK Potassium Channels Suppress Cavα2δ Subunit Function to Reduce Inflammatory and Neuropathic Pain. | 2.78e-05 | 2 | 184 | 2 | 29466724 | |
| Pubmed | Myosin heavy chain composition of the human genioglossus muscle. | 2.78e-05 | 2 | 184 | 2 | 22337492 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 24386388 | ||
| Pubmed | KIF13B enhances the endocytosis of LRP1 by recruiting LRP1 to caveolae. | 2.78e-05 | 2 | 184 | 2 | 24469637 | |
| Pubmed | Dysregulated Smooth Muscle Cell BMPR2-ARRB2 Axis Causes Pulmonary Hypertension. | 2.78e-05 | 2 | 184 | 2 | 36744494 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 18495803 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 29375207 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 36801171 | ||
| Pubmed | Phosphorylation of human Rad9 is required for genotoxin-activated checkpoint signaling. | 2.78e-05 | 2 | 184 | 2 | 12709442 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 24584352 | ||
| Pubmed | Plexin/neuropilin complexes mediate repulsion by the axonal guidance signal semaphorin 3A. | 2.78e-05 | 2 | 184 | 2 | 10781943 | |
| Pubmed | Mutations revealed by sequencing the 5' half of the gene for ataxia telangiectasia. | 2.78e-05 | 2 | 184 | 2 | 8789452 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 25074978 | ||
| Pubmed | Gro/TLE enables embryonic stem cell differentiation by repressing pluripotent gene expression. | 2.78e-05 | 2 | 184 | 2 | 25446531 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 16575183 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 9199932 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 15705893 | ||
| Pubmed | Small ubiquitin-like modifier modification of arrestin-3 regulates receptor trafficking. | 2.78e-05 | 2 | 184 | 2 | 21118812 | |
| Pubmed | Different pathways regulate expression of the skeletal myosin heavy chain genes. | 2.78e-05 | 2 | 184 | 2 | 11551968 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 33687949 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 12070169 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 28578349 | ||
| Pubmed | Type IIx myosin heavy chain transcripts are expressed in type IIb fibers of human skeletal muscle. | 2.78e-05 | 2 | 184 | 2 | 7545970 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 28263310 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 16697011 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 11278446 | ||
| Pubmed | Rab40c regulates focal adhesions and PP6 activity by controlling ANKRD28 ubiquitylation. | 3.09e-05 | 12 | 184 | 3 | 35512830 | |
| Pubmed | All Tcf HMG box transcription factors interact with Groucho-related co-repressors. | 3.09e-05 | 12 | 184 | 3 | 11266540 | |
| Pubmed | Contractile protein gene expression in primary myotubes of embryonic mouse hindlimb muscles. | 4.01e-05 | 13 | 184 | 3 | 8404542 | |
| Pubmed | 4.01e-05 | 13 | 184 | 3 | 22735158 | ||
| Pubmed | INTS3 TRRAP BIRC6 HAUS4 N4BP2 SAP30BP INTS4 ACIN1 ANKRD28 L3MBTL3 KDM6A | 4.47e-05 | 469 | 184 | 11 | 27634302 | |
| Pubmed | 5.08e-05 | 14 | 184 | 3 | 17202186 | ||
| Pubmed | 5.08e-05 | 14 | 184 | 3 | 27184118 | ||
| Pubmed | 5.40e-05 | 39 | 184 | 4 | 38690566 | ||
| Pubmed | Exome sequencing supports a de novo mutational paradigm for schizophrenia. | 5.97e-05 | 40 | 184 | 4 | 21822266 | |
| Pubmed | 6.33e-05 | 15 | 184 | 3 | 9291577 | ||
| Pubmed | TLR2, TLR4 and CD86 gene polymorphisms in recurrent aphthous stomatitis. | 8.32e-05 | 3 | 184 | 2 | 25482673 | |
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 25567808 | ||
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 8808280 | ||
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 17576816 | ||
| Pubmed | TLR4-mediated expulsion of bacteria from infected bladder epithelial cells. | 8.32e-05 | 3 | 184 | 2 | 19706440 | |
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 21470888 | ||
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 10097102 | ||
| Pubmed | Beta-arrestins regulate a Ral-GDS Ral effector pathway that mediates cytoskeletal reorganization. | 8.32e-05 | 3 | 184 | 2 | 12105416 | |
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 19195606 | ||
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 18625214 | ||
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 31980634 | ||
| Pubmed | Differential expression of plexin-A subfamily members in the mouse nervous system. | 8.32e-05 | 3 | 184 | 2 | 11241833 | |
| Pubmed | Presynaptic α2δ subunits are key organizers of glutamatergic synapses. | 8.32e-05 | 3 | 184 | 2 | 33782113 | |
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 20497256 | ||
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 32301540 | ||
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 17449237 | ||
| Pubmed | Interaction of PTPRO and TLR4 signaling in hepatocellular carcinoma. | 8.32e-05 | 3 | 184 | 2 | 25034527 | |
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 20980003 | ||
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 27397516 | ||
| Pubmed | Transition of myosin heavy chain isoforms in human laryngeal abductors following denervation. | 8.32e-05 | 3 | 184 | 2 | 26059207 | |
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 26241338 | ||
| Pubmed | Functional equivalence of the clathrin heavy chains CHC17 and CHC22 in endocytosis and mitosis. | 8.32e-05 | 3 | 184 | 2 | 19509056 | |
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 32780107 | ||
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 16709832 | ||
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 29091353 | ||
| Pubmed | Plexins promote Hedgehog signaling through their cytoplasmic GAP activity. | 8.32e-05 | 3 | 184 | 2 | 36169302 | |
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 26505972 | ||
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 21050672 | ||
| Pubmed | Sepsis induces an increase in thick ascending limb Cox-2 that is TLR4 dependent. | 8.32e-05 | 3 | 184 | 2 | 17634395 | |
| Pubmed | Tle corepressors are differentially partitioned to instruct CD8+ T cell lineage choice and identity. | 8.32e-05 | 3 | 184 | 2 | 30045946 | |
| Interaction | KRT8 interactions | USP53 MYH1 KRT32 PPP6R1 KLC4 BIRC6 HAUS4 KIF15 N4BP2 ANKRD28 AKAP11 USP4 FGD5 CRYBG3 SIPA1L2 ZRANB1 | 2.49e-06 | 441 | 181 | 16 | int:KRT8 |
| GeneFamily | Myosin heavy chains | 1.35e-04 | 15 | 124 | 3 | 1098 | |
| GeneFamily | WD repeat domain containing | 4.52e-04 | 262 | 124 | 8 | 362 | |
| GeneFamily | Protein phosphatase 6 regulatory subunits | 6.87e-04 | 6 | 124 | 2 | 699 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 1.18e-03 | 115 | 124 | 5 | 769 | |
| GeneFamily | Ring finger proteins|Baculoviral IAP repeat containing|Caspase recruitment domain containing | 1.27e-03 | 8 | 124 | 2 | 419 | |
| GeneFamily | Plexins | 1.63e-03 | 9 | 124 | 2 | 683 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 2.59e-03 | 40 | 124 | 3 | 321 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.11e-07 | 193 | 183 | 9 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.28e-07 | 165 | 183 | 8 | 9de841c1c95967c562720feba930246debc626fd | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.28e-07 | 165 | 183 | 8 | a612a7d3a5415ecacc3df8fbff0ce498f982aad0 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal--glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.28e-07 | 165 | 183 | 8 | cdc94a640ec01c6892521bcd6f0ee0a66ff23866 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-06 | 190 | 183 | 8 | f1363f7806cfc4f14fbc1b0e8dac2de813a88eee | |
| ToppCell | facs-Lung-nan-3m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-06 | 195 | 183 | 8 | 7f9b7f15006610ad591063d90e90367bd6083c7f | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_macrophage-stroma-stromal_macrophage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.63e-06 | 197 | 183 | 8 | 075044c17f1c52008cd3c292c15cbf485b50411e | |
| ToppCell | VE-mono1-|VE / Condition, Cell_class and T cell subcluster | 1.69e-06 | 198 | 183 | 8 | 2959d6e4992c36040ec9637f5a2daed02b35cf30 | |
| ToppCell | VE-mono1|VE / Condition, Cell_class and T cell subcluster | 1.69e-06 | 198 | 183 | 8 | c742871b8ec4720b1848991551c7c1f4000ebd85 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Radial_glial-gliogenic/outer_RGCs_and_astrocytes|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 1.82e-06 | 200 | 183 | 8 | 792fef1f3e47ce5c131fedfad55075fc254aeead | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.01e-06 | 167 | 183 | 7 | fe3338f99f94c0dac37e3d649dfdce82e4a56022 | |
| ToppCell | 368C-Myeloid-Monocyte-CD16+_Monocyte|Monocyte / Donor, Lineage, Cell class and subclass (all cells) | 6.75e-06 | 170 | 183 | 7 | 4a19c7e3bb0f9c2601a10debe7000066789b4150 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.16e-06 | 175 | 183 | 7 | 31f0fb2e47e357dbf9c15436b7df85b3c370ded7 | |
| ToppCell | facs-Aorta|facs / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.47e-06 | 176 | 183 | 7 | 0b3491451be02c18a16cdb875645be47eb867a7f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.80e-06 | 180 | 183 | 7 | ea7a1ccf0dd3bb5af5df87501f873e7339a824b3 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____fenestrated_capillary_endothelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.80e-06 | 180 | 183 | 7 | 79c5725f02e038d0187f4a1e1591f2492538aa57 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.80e-06 | 180 | 183 | 7 | 544fb373a3346186ec60afe2cfcf141bb04a1eed | |
| ToppCell | Bronchial_Biopsy-Mesenchymal-Smooth_muscle|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 9.80e-06 | 180 | 183 | 7 | 7085a851807e6a833965e1366946db0bbc5174e2 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-2|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.02e-05 | 181 | 183 | 7 | 9d5b331cabc5524f0a9fd8b571e87be4c447c7d4 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-large_intestine_goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-05 | 183 | 183 | 7 | 5a936fb07074cec753bf19e3e3e52499605ea22c | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-05 | 183 | 183 | 7 | 07c18ccc45ddc9c22e482bd9ffb87f46ebcfe473 | |
| ToppCell | BAL-Severe-Myeloid-Macrophage|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.17e-05 | 185 | 183 | 7 | ae966929fb5bbb08ffcbac76cb21941638727f55 | |
| ToppCell | BAL-Severe-Myeloid-Macrophage-transitional_Macro-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.17e-05 | 185 | 183 | 7 | 3beebaa92275086b1fae5f8c0c3d54016c5ba2aa | |
| ToppCell | BAL-Severe-Myeloid-Macrophage-transitional_Macro|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.17e-05 | 185 | 183 | 7 | 42939b294ea3e871274d8b73124c850dc1904fd2 | |
| ToppCell | BAL-Severe-Myeloid-Macrophage-transitional_Macro|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.17e-05 | 185 | 183 | 7 | 7a3612520ae4f0cd61480eadba31eecce001419d | |
| ToppCell | BAL-Severe-Myeloid-Macrophage-transitional_Macro-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.17e-05 | 185 | 183 | 7 | ceff11cfa679147ccfd0a0f8079e697a6bea34d9 | |
| ToppCell | BAL-Severe-Myeloid-Macrophage|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.17e-05 | 185 | 183 | 7 | 9aea5ed8f9cee5ee933891203aac7adb85d68201 | |
| ToppCell | Severe_COVID-19-Myeloid-transitional_Macro|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.17e-05 | 185 | 183 | 7 | f7ef0d7740b4cfedc38846e802898c402dc411fd | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-1|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.26e-05 | 187 | 183 | 7 | a716b64ca03d9b61da765bf87f065ac9393303f1 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.30e-05 | 188 | 183 | 7 | 74f7d216209cabdc96b2d46685b0ae017fdcc8fc | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.30e-05 | 188 | 183 | 7 | 3f47395db7e6159fc95810545bad4b6e028464c5 | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Gen_Intermediate|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.35e-05 | 189 | 183 | 7 | 5d7ae1ead7f4fbaeec26f651833c9c2106e1e4d1 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.39e-05 | 190 | 183 | 7 | 474cbbab8f3b0a6881fa6c92edb78e43999f9ab0 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.39e-05 | 190 | 183 | 7 | a3c6eec6df052105ab78b7e3c78f94218d5912eb | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Radial_glial-RGCs_early_2|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 1.44e-05 | 191 | 183 | 7 | 06107849463a1ccb78a5ccd3ae31619ef6bedda3 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-05 | 192 | 183 | 7 | 6c106b91e46eabbe686a52a65a9c94ad9cbe9390 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.49e-05 | 192 | 183 | 7 | c07d7b40b2aa4eb27ac85801c014a656e2fd01dc | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.49e-05 | 192 | 183 | 7 | 04f5a2e3dd6beff027b89d66eefdd92036e041af | |
| ToppCell | Control-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.54e-05 | 193 | 183 | 7 | aff0649c73c634bc6ff0dc7759b4693a9236bf05 | |
| ToppCell | Control-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.54e-05 | 193 | 183 | 7 | c5f9fe03e64c211d4bcd4959e5b32f14841e336a | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.54e-05 | 193 | 183 | 7 | 097a244cf37ce6c1ace9bae56beb7de59442cd6b | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.59e-05 | 194 | 183 | 7 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.59e-05 | 194 | 183 | 7 | 12496bc964d1c572241410524a89ca1a9fdb7e34 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.59e-05 | 194 | 183 | 7 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | Non-neuronal-Non-dividing|World / Primary Cells by Cluster | 1.59e-05 | 194 | 183 | 7 | 0add09d97192b34bd506209ab5f1a77182f498fc | |
| ToppCell | Bronchial_Biopsy-Immune-Luminal_Macrophages|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.65e-05 | 195 | 183 | 7 | 6800c17026ec6c56132bf4664b8fcd74d7836579 | |
| ToppCell | droplet-Mammary_Gland-nan-18m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-05 | 195 | 183 | 7 | c771ac1db8bd5f3a80bd3484094a58c28983f97b | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-05 | 195 | 183 | 7 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | 3'_v3-Lung|World / Manually curated celltypes from each tissue | 1.70e-05 | 196 | 183 | 7 | a04f8384b734ce67ec402e64bd891a6274f04744 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.70e-05 | 196 | 183 | 7 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-05 | 196 | 183 | 7 | 00f9171da4c791619e8c4c8c3c7da578c96a30ed | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.70e-05 | 196 | 183 | 7 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-05 | 196 | 183 | 7 | 61bee32ca299219f31a30b57124e44e85b798e9f | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 1.76e-05 | 197 | 183 | 7 | 30dbc05ea66892d2e18ff375ffa86d1db7bc4083 | |
| ToppCell | Mesenchymal_cells-Arteriolar_fibro.|Mesenchymal_cells / Lineage and Cell class | 1.76e-05 | 197 | 183 | 7 | cb321836980e7b4efbb9284c6af7ccd34079d2be | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Macroglial-Astroglia|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.82e-05 | 198 | 183 | 7 | 715ecad21f572b195ff3b78216b1a7b32bbb4ace | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.82e-05 | 198 | 183 | 7 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | COVID-19_Mild-Classical_Monocyte|COVID-19_Mild / Disease condition and Cell class | 1.82e-05 | 198 | 183 | 7 | 30ada3de865b6fb2b14196a1cbfd4740c6a57ce3 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Macroglial|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.82e-05 | 198 | 183 | 7 | 9d03768f8b6c74e060c5f045508538f9b331f469 | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.82e-05 | 198 | 183 | 7 | 1e1ea54f0c234f3b6d29064c4881d8a0c0949a75 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.88e-05 | 199 | 183 | 7 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Type_2_alveolar|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.88e-05 | 199 | 183 | 7 | e28ace2ca680c6154398e17110aa1838dd7a5548 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.88e-05 | 199 | 183 | 7 | e459d5aa63c83f960562be33cea8182b0556eabf | |
| ToppCell | BAL-Severe-cDC_0|Severe / Compartment, Disease Groups and Clusters | 1.88e-05 | 199 | 183 | 7 | d39be8b173156bf87baddd3caed4b35597c53ea1 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Macroglial-Astrocyte|10w / Sample Type, Dataset, Time_group, and Cell type. | 1.94e-05 | 200 | 183 | 7 | 75f5ea38fbd341b80a8058077a04447f0e0eea28 | |
| ToppCell | COVID-mono1-|COVID / Condition, Cell_class and T cell subcluster | 1.94e-05 | 200 | 183 | 7 | 445a1aab962673dcc926c33ce9bed5ede9c41c57 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.94e-05 | 200 | 183 | 7 | f6be0f24e607abb9007823a54fb0b24d04990a89 | |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.94e-05 | 200 | 183 | 7 | 362706445edb33b313684efe50b1f44f5f816e67 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Macroglial-Astrocyte|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.94e-05 | 200 | 183 | 7 | 4fe3b2d80c567c18621bff3341f9a73578c81621 | |
| ToppCell | COVID-mono1|COVID / Condition, Cell_class and T cell subcluster | 1.94e-05 | 200 | 183 | 7 | bd002c54305c746c07b7418a2084195e9c852ec5 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3_mon-Radial_glial|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.94e-05 | 200 | 183 | 7 | 49197316231e45f8c9f007f55b036600f7195922 | |
| ToppCell | severe-HLA-DR-_S100A+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.94e-05 | 200 | 183 | 7 | db7046741706376682d164c385c4701aebefc2e6 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3_mon-Radial_glial-RG|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.94e-05 | 200 | 183 | 7 | dea7928d6ceb7a347f56c6d0c9c7a56b7a2c0a80 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Radial_glial|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 1.94e-05 | 200 | 183 | 7 | ed4a41cb6782541d8fc928aaa12cf03bc1c630a2 | |
| ToppCell | control-HLA-DR-_S100A+_Monocyte|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.94e-05 | 200 | 183 | 7 | 9e3e13a68bc1110fa000ec2d80f4c654ddbce17e | |
| ToppCell | COVID-19_Convalescent-PLT_3|World / Disease Group and Platelet Clusters | 2.20e-05 | 137 | 183 | 6 | bb54bb81b450462ad521b57e1a07a80ce1678e67 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Cortical_neuron|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 3.41e-05 | 148 | 183 | 6 | a1269312903fc27830c1835dabf660c659a711be | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_1|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.26e-05 | 160 | 183 | 6 | 5cd4fbbd2ce671a8377416eff94041a111375dee | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Ctxn3_Sla|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.64e-05 | 162 | 183 | 6 | 4d13c271b4f63cf32980e5643b5d5951165fe8b5 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.64e-05 | 162 | 183 | 6 | d712bc31840ad1523e3dbf884acbb428a8995001 | |
| ToppCell | E12.5-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.84e-05 | 163 | 183 | 6 | c21114826bee1b05b411984326fef6b6e0d05316 | |
| ToppCell | E12.5-Endothelial-lymphatic_endothelial_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.84e-05 | 163 | 183 | 6 | 5d49414432db259a19df50d7944581d00b69f537 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.84e-05 | 163 | 183 | 6 | cab65dabeea58141c649e4fec5e0123beb3de1b3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.04e-05 | 164 | 183 | 6 | 01a7c335897128d3478b8b9b44fb461cab493084 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_l12|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.24e-05 | 165 | 183 | 6 | 6dda1c7fd812792bd2e4fb1a7ccb82a3552b0a3b | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.24e-05 | 165 | 183 | 6 | 4e13fccd32029e2879e85f8966e582a46c09e4aa | |
| ToppCell | 368C-Myeloid-Monocyte-CD16+_Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 6.68e-05 | 167 | 183 | 6 | dbd2b9f2f4ba7be5fdf8318094e6b078cb1d1c43 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.68e-05 | 103 | 183 | 5 | 3f4e4600c8a9af3534479ca19905c3d31c4c55bb | |
| ToppCell | facs-Liver-Hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.90e-05 | 168 | 183 | 6 | 4ae9e9d93bcd6f4d5815e57fd5afa7a3398a0ec1 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.90e-05 | 168 | 183 | 6 | 04e168fe1d6f5f9e3d3bf9d7c13e800e3594868a | |
| ToppCell | facs-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.13e-05 | 169 | 183 | 6 | 454b92b9b67299a64278c010db033ca5b9d217a0 | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-Exhausted_Tfh|T/NK_cells / Location, Cell class and cell subclass | 7.13e-05 | 169 | 183 | 6 | 625788d86f0ceebcf2653a251db1f1a9f9746d29 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Efna5_(Deep_layer_pyramidal_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 7.15e-05 | 54 | 183 | 4 | 13431c23a110070a11de41773233a8d6583d902c | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Efna5_(Deep_layer_pyramidal_cells)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 7.15e-05 | 54 | 183 | 4 | cd64ee5c47df5dba0cea954cb115a8de0efb55d1 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.86e-05 | 172 | 183 | 6 | e15ab284df6dd241d4481f98864b18c39d757b8c | |
| ToppCell | Control-MAIT|Control / Disease group and Cell class | 7.86e-05 | 172 | 183 | 6 | 552bc62e8e8bb0ac1cd0452f4410a3af087787eb | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.64e-05 | 175 | 183 | 6 | 795a6564d5a75ffd35d39f5274b9e8d28708bbc8 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-mature_enterocytic-Paneth|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.64e-05 | 175 | 183 | 6 | bffa623511ceb0b9bf76d87f9a10cfadfe0e940f | |
| ToppCell | Thalamus-Neuronal-Excitatory|Thalamus / BrainAtlas - Mouse McCarroll V32 | 8.92e-05 | 176 | 183 | 6 | d2bbf13d21fb7582d7e5f90cd61a4ebe1cfccd66 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_activate-7|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.92e-05 | 176 | 183 | 6 | dde46f06f6fc3f7ba83be91a0ee6231790955e3e | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 2.47e-05 | 10 | 177 | 3 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 2.47e-05 | 10 | 177 | 3 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 2.47e-05 | 10 | 177 | 3 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 2.47e-05 | 10 | 177 | 3 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 2.47e-05 | 10 | 177 | 3 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 2.47e-05 | 10 | 177 | 3 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 2.47e-05 | 10 | 177 | 3 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 2.47e-05 | 10 | 177 | 3 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 4.49e-05 | 12 | 177 | 3 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 4.49e-05 | 12 | 177 | 3 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 5.81e-05 | 13 | 177 | 3 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 9.16e-05 | 15 | 177 | 3 | DOID:0050646 (implicated_via_orthology) | |
| Disease | lysophosphatidylcholine 22:6 measurement | 1.62e-04 | 18 | 177 | 3 | EFO_0010365 | |
| Disease | Glioma | 1.82e-04 | 87 | 177 | 5 | C0017638 | |
| Disease | anorectal malformation | 1.92e-04 | 19 | 177 | 3 | MONDO_0019938 | |
| Disease | palmitoleoyl-protein carboxylesterase NOTUM measurement | 2.13e-04 | 4 | 177 | 2 | EFO_0802842 | |
| Disease | Uveal Melanoma | 2.91e-04 | 53 | 177 | 4 | EFO_1000616 | |
| Disease | Schizophrenia | NTRK2 RIMS3 SREBF2 TRRAP UGT1A3 SLC26A7 TLR4 SAP30BP LRP1 PLA2G1B ATM CTNNA2 GNAS PLXNA2 DNMT3B | 2.99e-04 | 883 | 177 | 15 | C0036341 |
| Disease | Diffuse interstitial pulmonary fibrosis | 5.28e-04 | 6 | 177 | 2 | cv:C0085786 | |
| Disease | lung small cell carcinoma (is_implicated_in) | 6.23e-04 | 28 | 177 | 3 | DOID:5409 (is_implicated_in) | |
| Disease | lung adenocarcinoma | 6.58e-04 | 174 | 177 | 6 | EFO_0000571 | |
| Disease | Malignant Glioma | 8.43e-04 | 70 | 177 | 4 | C0555198 | |
| Disease | mixed gliomas | 8.43e-04 | 70 | 177 | 4 | C0259783 | |
| Disease | cardiomyopathy (implicated_via_orthology) | 8.89e-04 | 71 | 177 | 4 | DOID:0050700 (implicated_via_orthology) | |
| Disease | female breast cancer (is_implicated_in) | 9.78e-04 | 8 | 177 | 2 | DOID:0050671 (is_implicated_in) | |
| Disease | Colorectal Carcinoma | RALGDS PRSS1 SELENOP LGR5 MCM3AP TLR4 LRP1 ACIN1 GNAS LONRF2 KDM6A FBXW7 | 1.14e-03 | 702 | 177 | 12 | C0009402 |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.19e-03 | 195 | 177 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | Nephronophthisis | 1.25e-03 | 9 | 177 | 2 | cv:C0687120 | |
| Disease | Mammary Carcinoma, Human | 1.33e-03 | 525 | 177 | 10 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 1.33e-03 | 525 | 177 | 10 | C1257931 | |
| Disease | Mammary Neoplasms | 1.37e-03 | 527 | 177 | 10 | C1458155 | |
| Disease | otitis media (is_marker_for) | 1.56e-03 | 10 | 177 | 2 | DOID:10754 (is_marker_for) | |
| Disease | Breast Carcinoma | 1.60e-03 | 538 | 177 | 10 | C0678222 | |
| Disease | Inherited neuropathies | 1.78e-03 | 40 | 177 | 3 | C0598589 | |
| Disease | Pulmonary Hypertension | 1.78e-03 | 40 | 177 | 3 | C0020542 | |
| Disease | alanine measurement | 1.81e-03 | 86 | 177 | 4 | EFO_0009765 | |
| Disease | Cystic Kidney Diseases | 1.90e-03 | 11 | 177 | 2 | C1691228 | |
| Disease | cholelithiasis | 1.97e-03 | 88 | 177 | 4 | EFO_0004799 | |
| Disease | Multiple Myeloma | 2.05e-03 | 42 | 177 | 3 | C0026764 | |
| Disease | Malignant neoplasm of breast | MYH1 SREBF2 EDNRB CUL5 BMPR2 N4BP2 TLE3 LRRC7 FGD5 ATM LRBA L3MBTL3 HSPA14 DNMT3B FBXW7 | 2.14e-03 | 1074 | 177 | 15 | C0006142 |
| Disease | gallbladder carcinoma (is_marker_for) | 2.27e-03 | 12 | 177 | 2 | DOID:4948 (is_marker_for) | |
| Disease | Gastric Adenocarcinoma | 2.50e-03 | 45 | 177 | 3 | C0278701 | |
| Disease | phosphatidylcholine 40:7 measurement | 2.67e-03 | 13 | 177 | 2 | EFO_0021477 | |
| Disease | autoimmune thrombocytopenic purpura (is_marker_for) | 2.67e-03 | 13 | 177 | 2 | DOID:8924 (is_marker_for) | |
| Disease | Nephronophthisis | 2.67e-03 | 13 | 177 | 2 | C0687120 | |
| Disease | amino acid measurement | CACNA2D1 SELENOP MED10 CLTCL1 SMURF1 CCNT2 RERGL KCNMA1 LTBP1 LRBA PLXNA2 | 2.73e-03 | 678 | 177 | 11 | EFO_0005134 |
| Disease | myopathy (implicated_via_orthology) | 3.01e-03 | 48 | 177 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | Carcinomatosis | 3.09e-03 | 163 | 177 | 5 | C0205699 | |
| Disease | Carcinoma, Spindle-Cell | 3.09e-03 | 163 | 177 | 5 | C0205697 | |
| Disease | Undifferentiated carcinoma | 3.09e-03 | 163 | 177 | 5 | C0205698 | |
| Disease | Anaplastic carcinoma | 3.09e-03 | 163 | 177 | 5 | C0205696 | |
| Disease | epilepsy (implicated_via_orthology) | 3.09e-03 | 163 | 177 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | Hamman-Rich syndrome | 3.11e-03 | 14 | 177 | 2 | C0085786 | |
| Disease | Carcinoma | 3.17e-03 | 164 | 177 | 5 | C0007097 | |
| Disease | Medulloblastoma | 3.38e-03 | 50 | 177 | 3 | C0025149 | |
| Disease | omega-6:omega-3 polyunsaturated fatty acid ratio | 3.38e-03 | 50 | 177 | 3 | EFO_0010732 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 3.57e-03 | 15 | 177 | 2 | C0496930 | |
| Disease | autoimmune thrombocytopenic purpura (is_implicated_in) | 3.57e-03 | 15 | 177 | 2 | DOID:8924 (is_implicated_in) | |
| Disease | Benign neoplasm of bladder | 3.57e-03 | 15 | 177 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 3.57e-03 | 15 | 177 | 2 | C0154091 | |
| Disease | colorectal cancer | SLC6A18 CACNA2D1 RTEL1 RANBP6 UNC45A HDDC3 ACTR1B LRP1 GNAS LRBA | 3.66e-03 | 604 | 177 | 10 | MONDO_0005575 |
| Disease | level of triacylglycerol (56:6) in blood serum | 4.06e-03 | 16 | 177 | 2 | OBA_2020007 | |
| Disease | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 4.06e-03 | 16 | 177 | 2 | C0334634 | |
| Disease | migraine without aura, susceptibility to, 4 | 4.06e-03 | 16 | 177 | 2 | MONDO_0011847 | |
| Disease | clonal hematopoiesis mutation measurement | 4.43e-03 | 55 | 177 | 3 | EFO_0020949 | |
| Disease | idiopathic pulmonary fibrosis | 4.90e-03 | 57 | 177 | 3 | EFO_0000768 | |
| Disease | non-alcoholic fatty liver disease | 4.92e-03 | 182 | 177 | 5 | EFO_0003095 | |
| Disease | bipolar disorder, sex interaction measurement | 5.14e-03 | 18 | 177 | 2 | EFO_0008343, MONDO_0004985 | |
| Disease | sinusitis (is_marker_for) | 5.14e-03 | 18 | 177 | 2 | DOID:0050127 (is_marker_for) | |
| Disease | Carcinoma of bladder | 5.14e-03 | 18 | 177 | 2 | C0699885 | |
| Disease | Withdrawal Symptoms | 5.14e-03 | 58 | 177 | 3 | C0087169 | |
| Disease | urate measurement, spine bone mineral density | 5.14e-03 | 58 | 177 | 3 | EFO_0004531, EFO_0007701 | |
| Disease | Drug Withdrawal Symptoms | 5.14e-03 | 58 | 177 | 3 | C0086189 | |
| Disease | Substance Withdrawal Syndrome | 5.14e-03 | 58 | 177 | 3 | C0038587 | |
| Disease | Cocaine-Related Disorders | 5.48e-03 | 117 | 177 | 4 | C0236736 | |
| Disease | Insulin Resistance | 5.65e-03 | 60 | 177 | 3 | C0021655 | |
| Disease | Insulin Sensitivity | 5.65e-03 | 60 | 177 | 3 | C0920563 | |
| Disease | Usual Interstitial Pneumonia | 5.72e-03 | 19 | 177 | 2 | C4721509 | |
| Disease | Hamman-Rich Disease | 5.72e-03 | 19 | 177 | 2 | C4721508 | |
| Disease | Intellectual Disability | 5.76e-03 | 447 | 177 | 8 | C3714756 | |
| Disease | Hypertensive disease | 5.89e-03 | 190 | 177 | 5 | C0020538 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AELQASLSKYCDQLP | 521 | Q9BXT4 | |
| CANRKPLSQEFEAYI | 281 | P35503 | |
| QSNPKFLCADYAEQD | 1076 | Q9UKV3 | |
| PNATPEDKQLAALCY | 1051 | P51826 | |
| LAPLCNGLINSYEDK | 116 | Q8NHY2 | |
| ENIPLKLSEDCLYLN | 106 | P23141 | |
| CAEYRALLSPEQRNK | 51 | Q10588 | |
| NPCEYDLKFQRSVLD | 46 | Q9BZE9 | |
| PLLDTKCDAYLQQTQ | 116 | O60583 | |
| FILDCLSNYNPKDDR | 221 | P63010 | |
| NPNLYNDGKVCLSIL | 4656 | Q9NR09 | |
| RESYVNLCSNPEDKL | 181 | Q93034 | |
| NLCSNPEDKLQIYRD | 186 | Q93034 | |
| LLSNSELAETCQPYK | 256 | Q5JRM2 | |
| IAPREYCKDLNASDN | 686 | Q9NY47 | |
| NCQAELSPAASKYED | 906 | Q68DQ2 | |
| CNDLSNVNPARKGLY | 651 | Q9UBC3 | |
| PARLSCLSKNLNYDT | 491 | Q8IZ83 | |
| EDIQLTCYLSPKANA | 261 | Q9UIR0 | |
| PSQVRQKYDTNCDAA | 6 | Q9BXU8 | |
| EECPAASLLQKYTNN | 81 | Q8N888 | |
| QCLRAYKPRENDELA | 1516 | Q12774 | |
| ECKFRETLLPNNYNA | 156 | P10767 | |
| ACYLSINPQKDEALE | 221 | P42025 | |
| NCQKPDIAEKYLSAS | 291 | Q8N4X5 | |
| KCLEYLLRNDANPGI | 486 | O15084 | |
| KCPFIENQLQDTSRY | 231 | Q13489 | |
| CQIYENNPQLKESLD | 21 | Q9P2G1 | |
| KNQTCERTLDPYRNE | 1436 | Q9UKA4 | |
| KLTLYNQNDPNRCEL | 346 | P24530 | |
| QQANKAALYGELCAL | 201 | Q92624 | |
| EVLAEKCPNLTYLNL | 81 | Q9BTT0 | |
| DLAINKYEAICNQPV | 611 | Q9UI46 | |
| TNYDKNRLCPSLIQE | 116 | Q96G46 | |
| LKIQAYFNETADLPC | 26 | P42081 | |
| STAQYKCPVAQLEQD | 246 | P32121 | |
| KLPTSEALLDYQCQI | 21 | Q8IWF9 | |
| ALLELDPKYANQTCG | 191 | Q9HC84 | |
| AYCENPDIVLIGNKA | 121 | O00194 | |
| YQAATPGQDLLRCKI | 61 | Q99638 | |
| YLDFCEKNDTQPVNA | 86 | Q33E94 | |
| ANDALNAYVCKGLPQ | 71 | Q68E01 | |
| PAQAQKCYRDLALVS | 101 | Q68E01 | |
| IDLCKATSPADALQY | 41 | Q96HW7 | |
| RSQSQLDLCKDSPYE | 461 | P78411 | |
| SADDNLKTPAECLLY | 281 | Q9UND3 | |
| ANCPYSEINLNKDRI | 581 | Q96JM7 | |
| CLKDLCLNDPQYTTN | 191 | Q6ZRR7 | |
| FCTSYQNDDPLNALK | 386 | Q14207 | |
| YKDACTVDPVTNQNL | 141 | Q16654 | |
| YLLEKGADLNAQTCN | 196 | Q8N9V6 | |
| PNVARTKNNLASCYL | 376 | Q9NSK0 | |
| LASPRSCYKLFQEQQ | 491 | Q9UM07 | |
| QNSVILEKLQPDCDY | 356 | P23352 | |
| NLEYNQLTTFPKALC | 286 | A4D1F6 | |
| ACLILANKYCADPDA | 486 | Q12791 | |
| LLESKACLQDSYDNL | 856 | Q9NS87 | |
| QQEAELVQYPDCKSS | 151 | P13378 | |
| KPNDNLNCAGYCDAL | 141 | Q9ULD2 | |
| FNCQALRKLSIPDND | 66 | Q96NW7 | |
| QRALLGYADNQCKLE | 186 | Q9HC38 | |
| RKNPALCFLYDQSNS | 116 | P60608 | |
| DVNECLQLPKACAYQ | 4756 | Q8NDA2 | |
| VEGYLLQPDNRSCKA | 176 | Q07954 | |
| PYNDSIQAQKNDVCR | 116 | P14415 | |
| ADKLYNLRDLNRCTP | 121 | Q8N4P3 | |
| YRSLLENEDCKLPCN | 396 | Q14532 | |
| AIQCKNIPDYLNDRT | 436 | O60318 | |
| NQPQDAIKCYLNATR | 366 | O15550 | |
| EESYINFLAINQKCP | 376 | Q8NHQ9 | |
| KNLEIPQDCTYADQK | 1216 | Q8IY21 | |
| IPELENCKQNDSIFY | 2286 | Q5CZC0 | |
| QECYLQKEPLLFSCA | 751 | Q3V5L5 | |
| QSLNSADLLKALCYP | 391 | P13535 | |
| NIQAHLYKCPALRES | 801 | Q9UIW2 | |
| EYKTLILNCVNPDNE | 1496 | O75051 | |
| YNLNDASLCDNVLAP | 1351 | Q14766 | |
| QCALCPLKDSDDYAQ | 1561 | Q14766 | |
| LCNNKLYQLDGLSDI | 166 | Q9H1B4 | |
| QSLNSADLLKALCYP | 391 | Q9UKX2 | |
| CCLPNYEDDLLGNAK | 171 | Q96FX8 | |
| YLNDSLNKCSNGRLP | 26 | Q6ZNL6 | |
| LVVLKACDYSDPNQI | 506 | Q8NCW6 | |
| QQELLGLDCSKYSPE | 156 | Q96E22 | |
| KCLANLVSNAPYDRL | 541 | Q6AI08 | |
| LSLCYFNPKNSDEQK | 871 | P50851 | |
| YNVPVADADNCSLLQ | 286 | P05129 | |
| CSLLQKFEACNYPLE | 296 | P05129 | |
| QNLNSADLLKALCYP | 391 | P12882 | |
| KEFLYCLALNPECNS | 286 | Q1L5Z9 | |
| YCSDPNLVLDLKNLI | 391 | Q9Y2D4 | |
| NPQLYTKECLERALA | 76 | Q9BTT4 | |
| SADDNLKTPAECLLY | 281 | F8WFD2 | |
| LYAQLCLRLAEDAPN | 131 | P78344 | |
| QLCKEQYADPFALAQ | 266 | Q96T92 | |
| GNLPSLNYLVLCDNK | 186 | Q96CX6 | |
| AADLPLNRCKNRYTN | 956 | Q16827 | |
| EQLYTPASLKCSLQN | 41 | P41217 | |
| SCLQYLDARNTPLLD | 191 | O75864 | |
| DPDLVQYADCKLAAA | 101 | P17481 | |
| SLYPCSAQQLNEDLR | 76 | Q6P988 | |
| SLDCRKLPNKNDPNY | 131 | Q9ULW2 | |
| KPLSNVCSLYRRDQD | 971 | Q13315 | |
| LLAYPKLNRLCANEE | 346 | Q5T8I9 | |
| CPDSACKQDLLAYLQ | 766 | P26232 | |
| IAPRDYCNDLKISDN | 661 | P54289 | |
| LCGNYNQDPADDLKA | 3411 | Q9Y6R7 | |
| YKLNDLKNAAPCAVS | 306 | O75718 | |
| PCAVSYLLFDQNDKV | 316 | O75718 | |
| DSYGECLRNKDLPQQ | 241 | Q6P4F1 | |
| DCLADVDTKPAYQNL | 71 | Q96IK1 | |
| PYKLCNNQEENDAVS | 161 | Q49AR2 | |
| CSLPELYACIENFNK | 21 | Q5TBE3 | |
| LEPKDLLQAAQTCRY | 296 | Q969H0 | |
| DCSPNKNRYLNVVLN | 331 | Q8IX06 | |
| ASQNQERLCAFKDPY | 26 | Q13873 | |
| KQADYVPSDQDLLRC | 186 | P63092 | |
| KLLQSACNNYSIAPD | 606 | Q12967 | |
| SNLYCLKPTICSDQD | 31 | Q16553 | |
| YLLASQPVDKCQSQD | 476 | O15068 | |
| SACLALEKYLDNPNA | 596 | Q63ZY3 | |
| RNPLCNLLSFTYKLD | 211 | Q9BU64 | |
| PCNLSKEDLLQNPYF | 26 | Q9H6D7 | |
| IANTAYLQARKPSDC | 11 | Q8WTQ7 | |
| RNENIFNCLYKNPEA | 11 | Q9NV23 | |
| LYCQENSVDAAKPLL | 116 | Q9Y6X3 | |
| DDIAANCIYLNIPNK | 216 | O94760 | |
| YNLLEDLPSFSVCQK | 361 | O75473 | |
| SDPQAQKYIAESKCL | 76 | Q0VDF9 | |
| SCNNGYLDAIKLLLD | 496 | Q9Y283 | |
| EELTQPLELKCNYFN | 1806 | P56715 | |
| PEKCDNNQYFDISAL | 46 | Q5HYA8 | |
| NSCLNPILYAFLDEN | 311 | P41146 | |
| KCYLVNLNADPALNE | 446 | Q9H1H9 | |
| DKCFLVNLNADPALN | 446 | Q9NQT8 | |
| CSQLLAALTAYKQDD | 1076 | Q9NZ71 | |
| QLNLEIYDPCSQTQK | 51 | Q9H628 | |
| CLTSPQAYENQEQLK | 571 | Q92581 | |
| SYVNCARFPKEQNLV | 326 | Q9GZV8 | |
| KAIELNPANAVYFCN | 116 | O43765 | |
| KTCDPLYQQALLFDE | 216 | Q9UJD0 | |
| KSNDLVLSCPYFRNE | 401 | Q9P2F8 | |
| DRNAAICFSKAPYNK | 121 | P04054 | |
| NETINYEDPCAKRLA | 1056 | O60518 | |
| QASUYLCILQASKLE | 56 | P49908 | |
| TGYQRLDLCKLNPSD | 111 | Q9HCE7 | |
| ASYNSPRNDCQKDAV | 276 | Q96N87 | |
| LKNLPLVDNICAYAN | 601 | O95573 | |
| DLYKLNPQDFIGCLN | 146 | Q96AQ7 | |
| KIYIDSNNSPECFLR | 881 | P53675 | |
| EPILSYENILKCAFQ | 141 | Q96F83 | |
| TQDLYCLNESSKNIP | 171 | Q16620 | |
| LLQAANTTDDYRKCP | 211 | Q70EK8 | |
| DACARYLLFSKQPSQ | 241 | Q6DKK2 | |
| QAKPYENISLCQAKL | 241 | Q9NUW8 | |
| YLLELKLCENSDPTN | 136 | Q13107 | |
| DLNIKINFACSYPLD | 416 | P07911 | |
| KPLYELGQNDACLSL | 176 | Q9NXC5 | |
| FLYPNAGQLKCLEEL | 271 | Q99797 | |
| KSPVSQLDCLNRDNY | 521 | Q04727 | |
| ELLPQLCNLLNSEDY | 126 | O14787 | |
| YLNDDRQKQPSFCDL | 76 | Q5SVQ8 | |
| AKESLYCAQRNPADP | 781 | Q12772 | |
| LPDNAKQCFYEDIAQ | 41 | Q9Y3B3 | |
| NRLKQPADCLDGLYA | 766 | P30530 | |
| AYKKADPQEAINCLN | 91 | Q9H115 | |
| ACLASNYALAKENLA | 56 | Q86XT2 | |
| EVCSLLNPAAIYANN | 46 | Q9H857 | |
| NRNNYASVECGAKIL | 306 | Q9UBS9 | |
| NPSIYEKLIQFCAID | 161 | Q9UHR5 | |
| SPISQLDCLNRDNYI | 521 | Q04726 | |
| DENPNANLLEICYKD | 601 | Q9UPN7 | |
| YRNLASVADQLCKPN | 236 | Q96JL9 | |
| SVADQLCKPNALSYL | 241 | Q96JL9 | |
| LDAPVLSQAKCEASY | 161 | P07477 | |
| CQLLFNPRQADYDKD | 756 | P35442 | |
| NKVNPLLICSASLDY | 81 | A2RRH5 | |
| ASQSCPNEKCYLILD | 561 | Q8TE54 | |
| NDCSKAIQLNPSYIR | 176 | Q99614 | |
| KTPVAQLDCLNRDNY | 491 | Q04725 | |
| NRDNYIRSCKLLPDG | 501 | Q04725 | |
| DTFPYKCLNSLQVLD | 536 | O00206 | |
| NALAACNYLPQSREK | 1371 | Q9Y4A5 | |
| ACLDKAVEYGLIQPN | 926 | Q9H3U1 | |
| PCEEYNDRNKLNTRT | 136 | Q9UGI0 | |
| AKCCQNILLYFDDPS | 66 | Q8NBT3 | |
| ARDKPYNCQISHLLE | 411 | Q6ZS27 | |
| LLFCYADKEQPNLCT | 3321 | Q5THJ4 | |
| ACARLPHLDYNKENL | 446 | O15146 | |
| CFIKDNTLALESNYP | 226 | Q86UW6 | |
| NDALDNLRKVVPCYS | 111 | Q96NK8 |